These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16285976)

  • 1. Caspase-8, death-receptor signaling, and hepatocarcinogenesis: the Fas and the furious.
    Baskin-Bey ES; Gores GJ
    Gastroenterology; 2005 Nov; 129(5):1790-2. PubMed ID: 16285976
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The active caspase-8 heterotetramer is formed at the CD95 DISC.
    Lavrik I; Krueger A; Schmitz I; Baumann S; Weyd H; Krammer PH; Kirchhoff S
    Cell Death Differ; 2003 Jan; 10(1):144-5. PubMed ID: 12655304
    [No Abstract]   [Full Text] [Related]  

  • 4. The CD95(APO-1/Fas) DISC and beyond.
    Peter ME; Krammer PH
    Cell Death Differ; 2003 Jan; 10(1):26-35. PubMed ID: 12655293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TRAIL DISCussion: It is FADD and caspase-8!
    Peter ME
    Cell Death Differ; 2000 Sep; 7(9):759-60. PubMed ID: 11042670
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer.
    Liedtke C; Trautwein C
    Eur J Cell Biol; 2012; 91(6-7):582-9. PubMed ID: 22153863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death receptors leave a caspase footprint that Smacs of XIAP.
    Bratton SB; Cohen GM
    Cell Death Differ; 2003 Jan; 10(1):4-6. PubMed ID: 12655287
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling.
    Los M; Mozoluk M; Ferrari D; Stepczynska A; Stroh C; Renz A; Herceg Z; Wang ZQ; Schulze-Osthoff K
    Mol Biol Cell; 2002 Mar; 13(3):978-88. PubMed ID: 11907276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
    Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
    Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria.
    Denecker G; Vercammen D; Steemans M; Vanden Berghe T; Brouckaert G; Van Loo G; Zhivotovsky B; Fiers W; Grooten J; Declercq W; Vandenabeele P
    Cell Death Differ; 2001 Aug; 8(8):829-40. PubMed ID: 11526436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.
    Gil J; Esteban M
    Oncogene; 2000 Jul; 19(32):3665-74. PubMed ID: 10951573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways.
    Yin XM
    Cell Res; 2000 Sep; 10(3):161-7. PubMed ID: 11032168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
    Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
    Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.
    Holler N; Zaru R; Micheau O; Thome M; Attinger A; Valitutti S; Bodmer JL; Schneider P; Seed B; Tschopp J
    Nat Immunol; 2000 Dec; 1(6):489-95. PubMed ID: 11101870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential caspase-9-dependent signaling pathway between tumor necrosis factor receptor- and Fas-mediated hepatocyte apoptosis in mice.
    Imao M; Nagaki M; Imose M; Moriwaki H
    Liver Int; 2006 Feb; 26(1):137-46. PubMed ID: 16420519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
    Liu B; Fan Z
    Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation.
    Ruefli AA; Tainton KM; Darcy PK; Smyth MJ; Johnstone RW
    Cell Death Differ; 2002 Nov; 9(11):1266-72. PubMed ID: 12404126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
    Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
    Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tegillarca granosa extract Haishengsu induces apoptosis in human hepatocellular carcinoma cell line BEL-7402 via Fas-signaling pathways.
    Chen X; Han Y; Zhan S; Wang C; Chen S
    Cell Biochem Biophys; 2015 Mar; 71(2):837-44. PubMed ID: 25257131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
    Kern MA; Haugg AM; Koch AF; Schilling T; Breuhahn K; Walczak H; Fleischer B; Trautwein C; Michalski C; Schulze-Bergkamen H; Friess H; Stremmel W; Krammer PH; Schirmacher P; Müller M
    Cancer Res; 2006 Jul; 66(14):7059-66. PubMed ID: 16849551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.